Otsuka And Lundbeck Submit SNDA For FDA Review Of Brexpiprazole And Sertraline Combination As Potential Treatment For Ptsd
09/04/2024 07:02
April 9 (Reuters) - Otsuka Holdings Co Ltd 4578.T :
* OTSUKA HOLDINGS CO LTD: OTSUKA AND LUNDBECK SUBMIT SNDA
FOR FDA
REVIEW OF BREXPIPRAZOLE AND SERTRALINE COMBINATION AS POTENTIAL
TREATMENT FOR PTSD
Source text for Eikon: ID:nTSpi8a94e
Further company coverage: 4578.T
(Reporting by Tokyo Newsroom)
((+81345201189;))